Vimarsana
Biggest News Aggregation in the World

Generation Sequencing Laboratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Generation Sequencing Laboratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Generation Sequencing Laboratory Today - Breaking & Trending Today

iGene Laboratory Announces Launch of Whole Exome Sequencing Service - Vimarsana News

iGene Laboratory Announces Launch of Whole Exome Sequencing Service

SINGAPORE, Feb. 21, 2023 /PRNewswire/ --Singapore-based molecular diagnostics lab group iGene Laboratory announces the launch of FetalExome test service. FetalExome test is a whole exome sequencing (WES) test available for women with potentially complicated pregnancies. The test examines and analyses the gene regions that code for proteins, known as the exome, which plays a critical role as these proteins form the building blocks of cells and allows specialists to diagnose fetal abnormalities and reveal the causes of fetal complications. FetalExome is ordered when prenatal ultrasound imaging d...

Related Topics:
United StatesKane BlackGene Laboratory PteGuidelines CommitteeCollege Of American PathologistsGene LaboratoryPte LtdAmerican College Of Medical GeneticsGeneration Sequencing LaboratoryAmerican CollegeMedical GeneticsSouth East AsiaCurr Opin ObstetAmerican PathologistsAccredited Next Generation Sequencing LaboratoryNon Invasive Prenatal TestingFeb 21023 Prnewswire Singapore Based Molecular Diagnostics Lab Group Igene Laboratory Announces The Launch Of Fetalexome Test Service Isa Whole Exome Sequencing Wes Available For Women With Potentially Complicated Pregnancies Examines And Analyses Gene Regions That Code ProteinsNown As The ExomeHich Playsa Critical Role As These Proteins Form The Building Blocks Of Cells And Allows Specialists To Diagnose Fetal Abnormalities Reveal Causes Complications Fetalexome Is Ordered When Prenatal Ultrasound Imaging Detects Structural Anomalies That Suggestive Genetic Are Common Affect About 2 4 Pregnancies American College Medical Genetics Genomics Acmg Recommends Use Wes Whena Diagnosis Cannot Be Obtained Using Routine Methods Ina Fetus With One Or More Significant 1 Offered Asa Trio Analysis Where Sequencing Performed On Both Parents For Timely Clinical Management Decision Making Chief Executive Igene LaboratoryAne Black RemarkedUot As Arguably The Fetal Maternal Health Pioneer In South East AsiaE Are Proud To Launch Another Test Support Mother 39s Be And Their Babies Quot Mr Black Further Commented With Thousands Of Genes Analysed At The Same TimeAther Than One Ora Few Genes Ata TimeEtalexome Will Allow Doctors To Potentially Identify And Or Administer The Best Specific Treatments Efficiently Quot 1 Monaghan Kg
Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong - Vimarsana News

Molecular Diagnostics Developer INEX Innovate Announces Funding for New Research with The Chinese University of Hong Kong

Singapore-based diagnostics developer INEX Innovate brings The Chinese University of Hong Kong together to further research work on LEXI, INEX's fetal cell based non-invasive pre-natal diagnostics technology. SINGAPORE, July 26, 2022 /PRNewswire/ -- Singapore-based diagnostics developer and medical laboratory operator, INEX Innovate has contributed an undisclosed sum to leading Hong Kong university - The Chinese University of Hong Kong (CUHK), to collaborate and further research in the field of maternal fetal medicine. The CUHK Department of Obstetrics & Gynaecology (O&G) is world-...

Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts. - Vimarsana News

Asia's first molecular diagnostics company for women, INEX Innovate receives European CE-IVD Certification for its OvaCis(R) Rapid Test to detect cancer in ovarian cysts.

Revolutionary Ovarian Cancer Rapid Test Available Q4 2022 SINGAPORE, May 11, 2022 /PRNewswire/ -- Known as a pioneer in Asia's women's and fetal health industry, Singapore-based diagnostics